Amylin Pharmaceuticals Inc. Newsletter
-
GLP-1 Receptor Agonist Market Set to Witness Significant Growth by 2025-2032: Taro Pharmaceutical Industries, Novan Inc
28 Jan 2025 13:28 GMT
… ., Ltd.,
◘ AstraZeneca
◘ Intarcia Therapeutics Inc.
◘ Amylin Pharmaceuticals Inc.
◘ Sanofi
◘ Hanmi Pharm. Co …
-
Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors
28 Jan 2025 13:00 GMT
… , Inc. (now Nestle Health Science), Amylin Pharmaceuticals, Inc. (now Bristol-Myers Squibb …
-
Hypothalamic Obesity Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes
16 Jan 2025 20:01 GMT
… , Rhythm Pharmaceuticals, Inc., Amylin Pharmaceuticals, LLC, Novartis, Zafgen, … Rhythm Pharmaceuticals, Inc.
• Exenatide: Amylin Pharmaceuticals, LLC
• Octreotide: Novartis
• … , Rhythm Pharmaceuticals, Inc., Amylin Pharmaceuticals, LLC, Novartis, Zafgen, …
-
Beyond Amorphous Solid Dispersions: Novel Applications in Pharmaceutical Spray Drying
08 Jan 2025 23:09 GMT
… development positions at Ionis Pharmaceuticals, Amylin Pharmaceuticals, and the Immune Response Corporation …
-
GLP-1 Receptor Agonist Market Is Booming Worldwide 2024-2031: Novan Inc., Verrica Pharmaceuticals, AbbVie Inc., Sanofi
13 Dec 2024 07:03 GMT
… ., Ltd.,
◘ AstraZeneca
◘ Intarcia Therapeutics Inc.
◘ Amylin Pharmaceuticals Inc.
◘ Sanofi
◘ Hanmi Pharm. Co …
-
Versant startup sets out to make a new type of obesity drug
21 Nov 2024 15:55 GMT
… led R&D at Amylin Pharmaceuticals, which developed GLP-1 drugs …
-
Versant Ventures Unveils Pep2Tango Therapeutics Inc.
21 Nov 2024 13:07 GMT
… executive director for research at Amylin Pharmaceuticals Inc., where he was involved …
-
The Woman’s World Expert-Reviewed Glossary of GLP-1, Semaglutide and Telehealth
13 Nov 2024 17:14 GMT
… : Name-brand exenatide medication by Amylin Pharmaceuticals, injected twice daily. (Short-acting … : Name-brand exenatide medication by Amylin Pharmaceuticals, injected once weekly (Long-acting …
-
Diabetes Drug Market to Reach USD 85.67 Billion by 2032 with a 4.9% CAGR | SNS Insider
05 Nov 2024 11:52 GMT
…
• ARKRAY USA Inc.
• Bayer AG
• Amylin Pharmaceuticals Inc.
• Other players
Diabetes Drug …
-
Innovive, LLC Appoints Jamie S. Blose, Pharm.D, MBA, JD as Chief Executive Officer
01 Nov 2024 10:09 GMT
… companies including Rain Oncology, Genentech, Amylin Pharmaceuticals, NovaQuest, Quintiles and Glaxo Wellcome …
About
© 1995-2025